Banner: IPF Treatment


Whilst there is no cure for IPF, medications may help to stabilise the disease.1 In clinical trials, it was shown that medications are able to slow the decline of lung function in patients with IPF.

In some countries, one or two medications are approved for the treatment of IPF, and in other countries, no medications are approved.

In some cases, doctors may prescribe a medication “off-label”, that is when the medication has not been specifically approved for use in IPF. It is very important to talk to your doctor about the treatments that are available in your area and which ones may be suitable for you.

Your doctor may prescribe one of the following medications to you:


  • OFEV® (active substance: nintedanib)
  • Esbriet® (active substance: pirfenidone)


Both drugs are anti-fibrotic drugs, which means that they can help to reduce the building of new scarring and more stiffening of the lungs of IPF patients.

Medications in clinical trials

Currently there are a number of planned and ongoing clinical trials to test new and promising medications for treatment of IPF. If you want to know more about clinical trials in IPF, visit and talk to your doctor.


Patient guide

Patient guide: Moving forward


Backgrounder: IPF Treatment

What are the benefits of receiving medicinal treatment for IPF?

When shall a patient who is diagnosed with IPF initiate treatment?


  1. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.

This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

No, give me more info OK, i agree